Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Supplement Shows Promise for Improving Cancer-Related Cognitive Impairment

(MedPage Today) -- Cancer-related cognitive impairment (CRCI) in breast cancer survivors improved significantly after treatment with the glutamate regulator oxaloacetate, a preliminary single-arm clinical study showed. All 16 evaluable patients...

Supplement Shows Promise for Improving Cancer-Related Cognitive Impairment

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Friday 23 October →